Cart

Ohio-based cannabis company, Green Growth Brands (OTCQB: GGBXF) (CSE:GGB) recently announced that its acquiring Moxie for $310 million. Green Growth Brands also said that this agreement was reached through an all stock deal. Moxie is a multi state (MSO) cannabis firm that sells recreational and medical cannabis products through its 250 outlets and dispensaries in 5 states.

In its press release, Green Growth Brands stated that, “On closing, the combination will bring together two best‐in‐class cannabis operators and create a superior coast‐to‐coast cannabis player, with immediate access to nine key states including California, Florida, Nevada and Massachusetts, and up to 16 states total including Moxie’s expansion potential (and not including GGB’s CBD kiosk locations)”

With the acquisition, Green Growth Brands which currently focuses on Florida’s medical cannabis industry will have access to additional markets in Arizona, California, Nevada, New Jersey, and Pennsylvania. The deal is expected to be completed in the next 6 months. Moxie CEO Jordan Lams also expressed that the agreement is a great business move that would help both businesses grow.

{{cta(‘90438494-6bd0-4c05-aee6-ee36a536f0d4’)}}

The acquisition is in line with Green Growth Brands’ move to expand its business operations into new markets. The company is also expanding its CBD brand presence by partnering with U.S. retail stores such as Abercrombie & Fitch.

Green Growth Brands’ acquisition will enable the company to offer a more comprehensive product line up which includes both CBD and THC product lines that can be offered through mainstream retail stores and cannabis dispensaries.

Curious about how you can make money investing in cannabis? Sign up for Cannin Free Access and subscribe to the Cannin Chronicle. We’ll keep you informed on all things cannabis and even help you determine which cannabis companies have the highest growth potential.

Golden Leaf Holdings Expands Management Team

Risk of Prosecution for Marijuana-Related Companies. If you are considering investing in a company that is connected to the marijuana industry, be aware that marijuana-related companies may be at risk of federal, and perhaps state, criminal prosecution. The Department of Treasury recently issued guidance noting: “[T]he Controlled Substances Act (“CSA”) makes it illegal under federal law to manufacture, distribute, or dispense marijuana. Many states impose and enforce similar prohibitions. Notwithstanding the federal ban, as of the date of this guidance, 20 states and the District of Columbia have legalized certain marijuana-related activity.”